GLP-1RAs significantly reduce mortality, hospitalization, and AF progression compared to SGLT-2is in T2D with AF.
Glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter-2 inhibitors in adults with type 2 diabetes and atrial fibrillation: a multicenter comparative effectiveness cohort study of cardiovascular and arrhythmic outcomes.
Abstract
GLP-1RAs were associated with lower risks of all-cause mortality, hospitalization, MACE, and atrial fibrillation progression compared to SGLT-2is in adults with concurrent T2D and AF.